Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.
Versatope Therapeutics has raised $200K in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Versatope Therapeutics's investors include MassChallenge, Massachusetts Life Sciences Center, MassVentures, National Institute of Allergy and Infectious Diseases.
Versatope Therapeutics is headquartered in Lowell, United States.
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.
Versatope Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Versatope Therapeutics — Funding & Investors." VCBacked, May 16, 2025, https://www.vcbacked.co/company/versatope-therapeutics. Accessed July 21, 2026.
VCBacked. (2025). Versatope Therapeutics — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/versatope-therapeutics
{{cite web |title=Versatope Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/versatope-therapeutics |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated